IMUC OTC
EOM Pharmaceuticals Holdings, Inc.
1W: -1.9%
1M: +13.5%
3M: -20.6%
YTD: -18.5%
1Y: +269.5%
3Y: -47.0%
5Y: -66.9%
$0.16
+0.05 (+47.22%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
+44.2% ▲
Capital Expenditures
$3
+40.0% ▲
Free Cash Flow
-$1M
+44.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$69K
+61.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$3M | -$2M | -$2M | -$2M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $333K | $379K | $493K | -$345K | $391K |
| Other Non-Cash Items | $40K | -$355K | -$302K | -$443K | $38K |
| Operating Cash Flow | -$2M | -$3M | -$1M | -$3M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $4 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$4 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $3M | $2M | $1M | $2M | $1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $4M | $2M | $1M | $2M | $1M |
| Net Change in Cash | $1M | -$873K | -$335K | -$180K | -$69K |
| Cash End of Period | $1M | $613K | $278K | $99K | $30K |
| Free Cash Flow | -$2M | -$3M | -$1M | -$3M | -$1M |